BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma YS, Wang XF, Zhang YJ, Luo P, Long HD, Li L, Yang HQ, Xie RT, Jia CY, Lu GX, Chang ZY, Zhang JJ, Xue SB, Lv ZW, Yu F, Xia Q, Fu D. Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency. Mol Ther Oncolytics 2020;16:147-57. [PMID: 32055678 DOI: 10.1016/j.omto.2019.12.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Morgan EL, Chen Z, Van Waes C. Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma? Cancers (Basel) 2020;12:E2877. [PMID: 33036368 DOI: 10.3390/cancers12102877] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Yang JS, Yoon N, Kong M, Jung BH, Lee H, Park J. USP14 Regulates Cancer Cell Growth in a Fatty Acid Synthase-Independent Manner. Int J Mol Sci 2021;22:13437. [PMID: 34948233 DOI: 10.3390/ijms222413437] [Reference Citation Analysis]
3 Ma YS, Chu KJ, Ling CC, Wu TM, Zhu XC, Liu JB, Yu F, Li ZZ, Wang JH, Gao QX, Yi B, Wang HM, Gu LP, Li L, Tian LL, Shi Y, Jiang XQ, Fu D, Zhang XW. Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis. Mol Ther Nucleic Acids 2020;21:229-41. [PMID: 32585630 DOI: 10.1016/j.omtn.2020.05.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
4 Antao AM, Tyagi A, Kim KS, Ramakrishna S. Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics. Cancers (Basel) 2020;12:E1579. [PMID: 32549302 DOI: 10.3390/cancers12061579] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
5 Lee CS, Kim S, Hwang G, Song J. Deubiquitinases: Modulators of Different Types of Regulated Cell Death. Int J Mol Sci 2021;22:4352. [PMID: 33919439 DOI: 10.3390/ijms22094352] [Reference Citation Analysis]
6 Tian LL, Qian B, Jiang XH, Liu YS, Chen T, Jia CY, Zhou YL, Liu JB, Ma YS, Fu D, Ding ST. MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients. Int J Genomics 2021;2021:6670390. [PMID: 33816607 DOI: 10.1155/2021/6670390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Choi HS, Baek KH. Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes. Cell Mol Life Sci 2022;79:117. [PMID: 35118522 DOI: 10.1007/s00018-022-04132-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moon S, Muniyappan S, Lee SB, Lee BH. Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases. Int J Mol Sci 2021;22:6213. [PMID: 34207520 DOI: 10.3390/ijms22126213] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wu ZH, Zhou J, Hu GH, Liu J, Li WC, Lai XH, Liu M. LncRNA CASC2 inhibits lung adenocarcinoma progression through forming feedback loop with miR-21/p53 axis. Kaohsiung J Med Sci 2021;37:675-85. [PMID: 34337857 DOI: 10.1002/kjm2.12386] [Reference Citation Analysis]
10 Hsu FS, Lin WC, Kuo KL, Chiu YL, Hsu CH, Liao SM, Dong JR, Liu SH, Chang SC, Yang SP, Chen YT, Chang RJ, Huang KH. PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. Int J Mol Sci 2021;22:11706. [PMID: 34769137 DOI: 10.3390/ijms222111706] [Reference Citation Analysis]
11 Tundo GR, Sbardella D, Santoro AM, Coletta A, Oddone F, Grasso G, Milardi D, Lacal PM, Marini S, Purrello R, Graziani G, Coletta M. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges. Pharmacol Ther 2020;213:107579. [PMID: 32442437 DOI: 10.1016/j.pharmthera.2020.107579] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
12 Lei H, Wang J, Hu J, Zhu Q, Wu Y. Deubiquitinases in hematological malignancies. Biomark Res 2021;9:66. [PMID: 34454635 DOI: 10.1186/s40364-021-00320-w] [Reference Citation Analysis]
13 Hommen F, Bilican S, Vilchez D. Protein clearance strategies for disease intervention. J Neural Transm (Vienna) 2021. [PMID: 34689261 DOI: 10.1007/s00702-021-02431-y] [Reference Citation Analysis]
14 Kuchur OA, Kuzmina DO, Dukhinova MS, Shtil AA. The p53 Protein Family in the Response of Tumor Cells to Ionizing Radiation: Problem Development. Acta Naturae 2021;13:65-76. [PMID: 34707898 DOI: 10.32607/actanaturae.11247] [Reference Citation Analysis]